{"id":"W3187807747","doi":"","title":"BTK inhibitors approved in Canada for CLL: Strategies for adverse event management","year":2021,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Adverse effect; Chronic lymphocytic leukemia; Medicine; Tyrosine kinase; Oncology; Intensive care medicine; Pharmacology; Leukemia; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004455377,0.0005874651,0.0005081129,0.001977138,0.002395696,0.003485983,0.001233331,0.001282112,0.007536886],"category_scores_gemma":[0.0113662,0.0002477244,0.0007609853,0.00209964,0.001075368,0.00145361,0.001426496,0.002818721,0.001946133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01975646,"about_ca_system_score_gemma":0.05744456,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4455812,"about_ca_topic_score_gemma":0.7668082,"domain_scores_codex":[0.997033,0.0006174618,0.0002950881,0.0001257036,0.001613022,0.000315762],"domain_scores_gemma":[0.9901141,0.0008490044,0.001471946,0.0001869228,0.005806337,0.001571773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001327557,0.0001007144,0.006600663,0.00076662,0.00003533522,0.0005122225,0.0004039515,0.0006003951,0.001052487,0.006078218,0.3091052,0.6746113],"study_design_scores_gemma":[0.0001686219,0.0002423882,0.01833955,0.001960946,0.0001112808,0.001555089,0.0009251731,0.001130649,0.001319423,0.00534022,0.9688223,0.00008432313],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.01571366,0.1568697,0.0227039,0.5793142,0.004003404,0.001494642,0.002092691,0.00184623,0.2159615],"genre_scores_gemma":[0.248221,0.402096,0.09338766,0.1385137,0.007283343,0.0009696059,0.005004057,0.0006214888,0.1039032],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.5544188,"threshold_uncertainty_score":0.8859752,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1958820659671628,"score_gpt":0.5435071818024639,"score_spread":0.3476251158353012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}